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CHR GENE PROTEIN FUNCTION HUMAN PHENOTYPE (MUTANT MOUSE PHENOTYPES)
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6q23.3 (AHI1*) Jouberin; interacts with b-catenin 
in cilia 
Joubert syndrome. (Reduced brain and body size. Cerebellar, retinal, and kidney defects. Most die by P10. Neuron-specific loss 
leads to depressive-like phenotypes.)
7q35-q36.1 
(CNTNAP2*)
Caspr2, a neurexin family member; 
clusters voltage-gated K+ channels 
Recessive EPI syndrome, ASD, ADHD, TS, OCD. (Neuronal migration defects.  Reduced GABAergic neurons and decreased 
cortical synchrony. Seizures. Deficits in social, repetitive behaviors, and USV.) 
9q34.13 (TSC1) Hamartin, a growth inhibitory protein 
that negatively regulates the mTOR 
pathway
Tuberous Sclerosis type I. (Liver and neural tube defects. Die by E12. Abnormal kidney and liver growth in heterozygotes. 
Variable brain structure, function and behavior abnormalities in conditional mutants. Die at various postnatal ages. Neuron-
specific loss causes abnormal spine morphology and cortical excitability. Loss of LTD.)
10q23.31 (PTEN) Protein tyrosine phosphatase; 
negatively regulates the mTOR 
pathway
Cowden disease. (Placenta and germ cell defects. Die by E9.5. Neuron-specific loss alters synaptic physiology. Heterozygotes 
have prostate, skin and colon defects, and spontaneous tumors. Macrocephaly, neuronal hypertrophy, abnormal social 
interaction, and increased survival in conditional mutants.)
11q13.4 (DHCR7) Final enzyme in cholesterol 
biosynthetic pathway
Smith-Lemli-Opitz syndrome. (Craniofacial and lung abnormalities. Die by P1. Abnormal cholesterol regulation and enlarged 
bladders. Hypomorphic mutants are viable and fertile. Compound mutants have fused toes, enlarged ventricles, and 25% 
embryonic lethality.) 
12p13.33 
(CACNA1C)
a-1 subunit of a voltage-dependent 
Ca2+ channel
Timothy syndrome. (Die embryonically. Impaired pancreatic function. Motor defects and antidepressant-like behavior in 
heterozygotes; anxiety-like deficits in females. Neuron-specific loss, impaired cognition and LTP.) 
15q11.2 (UBE3A) Ubiquitination ligase; targets protein 
degradation system
Angelman syndrome. (Small brain, seizure susceptibility, motor and learning deficits. Reduced spine density and impaired LTP. 
Impaired synapse maturation and plasticity.) 
16p13.3 (TSC2) Tuberin; which negatively regulates 
the mTOR pathway
Tuberous Sclerosis type II. (Heart, neural tube, and motor defects. Purkinje cell death. Die by E12. Various tumors and axon 
guidance defects in heterozygotes. Dominant-negative mutant has enhanced anxiety-like behaviors; motor, learning, social 
behavior deficits.) 
17q11.2 (NF1) Neurofibromin; a GTPase activator 
and negative regulator of RAS 
signaling 
Neurofibromatosis. (Macrocephaly, small eyes, and heart defects. Delayed organ development. Embryonic lethal. Increased 
astrocytes and tumor susceptibility. LTP and learning and memory deficits in heterozygotes.) 
Xp21.2 (DMD) Dystrophin; cytoskeletal protein 
bridging ECM
Duchenne muscular dystrophy. (Muscle and heart defects in hemizygous males and homozygous females. Reduced fertility. 
Abnormal retinal electrophysiology and synapse organization, density, and maturation.)
Xp21.3 (ARX) Aristaless-related homeobox protein 
TF
LIS, XLID, EPI, ASD. (Hemizygous males die perinatally. Decreased inhibitory synaptic transmission. Males hemizygous for point 
mutations or triple repeat expansions have seizures. Defects in behavior and GABAergic neuron generation and migration.)
Xq27.3 (FMR1) Fragile X mental retardation protein; 
an RNA-binding protein that traffics 
mRNA 
Fragile X syndrome. (Seizures. Enlarged testes in males. Learning and social behavior defects. Dendritic spine abnormalities. 
Enhanced LTD and impaired LTP. Altered cortical drive and E/I neuronal cortical networks.) 
Xq28 (MECP2) MeCP2; involved in transcriptional 
regulation and chromatin 
organization
Rett syndrome. (Brain, breathing, and motor defects in hemizygous males. Mild cognitive and anxiety-like phenotypes in 
heterozygous females. Various conditional loss and postnatal reduction mimic null phenotypes in adult hemizygous males. 
Impaired excitatory synapses and spine morphology. Increased neuronal connectivity.) 
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2p16.3 (NRXN1) A neurexin; forms intracellular 
junctions through neuroligin binding
ASD, ID, language delay, SCZ. (Reduced startle and PPI. Enhanced anxiety-like behavior and motor learning. Impaired spatial 
memory. Defective LTP. Defects in excitatory synaptic strength and diminished NMDA/AMPA receptor current.) 
3p13 (FOXP1) A forkhead box TF ID, ASD, SLI. (Cardiovascular defects. Die embryonically.)
6q16.3 (GRIK2*) A postsynaptic glutamate receptor 
subunit
Recessive ID. (Increased sensitivity to drug-induced seizures. Elevated startle and pain threshold. Impaired synaptic plasticity 
and inhibitory transmission.) 
7q31.1 (FOXP2) A forkhead box TF SLI. (Growth retardation, reduced USV, cerebellar, motor and neurological defects. Perinatal death. Impaired LTD and plasticity.)
15q11-q13 ASD, EPI, ID. (Cleft palate in deletion mutants; die by P3; motor, and cognitive defects. Seizures. Increased newborn USV in 
maternal heterozygotes. Reduced activity, social interactions, and USV; increased anxiety-like behavior in duplications.) 
16p11.2 ASD, ADHD, ID, EPI, SCZ. (Mild structual brain defects and gene dose-dependent behavioral phenotypes.) 
17q11.2 (SLC6A4) 5-HT transporter ASD, OCD. (Heart defects. Hyperactive, aggressive, anxiety-like behaviors, and learning deficits.) 
22q11.21 DiGeorge syndrome, SCZ, ASD, ID. (Sensorimotor, learning, and memory deficits. Hyperactivity. Increased anxiety-like 
behavior.) 
22q13.33 
(SHANK3)
A PSD scaffold protein ASD. (Variable phenotypes including excessive grooming, anxiety-like behavior, and disrupted social interactions. Abnormal 
dendritic spines. Reduced synaptic transmission, LTP, LTD, and NMDAR-dependent responses.) 
Xp22.32-p22.31 
(NLGN4X)
A neuroligin; ligand for b-neurexins ASD, ID, TS, ADHD. (Reduced brain size. Social interaction and USV deficits.) 
Xq13.1 (NLGN3*) A neuroligin; ligand for b-neurexins ASD. (Reduced brain size. Abnormal learning, social behavior, USV, and olfaction. Hyperactivity, altered E/I balance shift caused 
by increased inhibitory synaptic transmission.) 
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1q42.2 (DISC1) Large transmembrane protein 
involved in neurite outgrowth and 
brain development
(Region-specific changes in neuronal morphology. Homozygote and heterozygote learning and memory deficits. Reduced 
neurogenesis and altered neuron distribution. Abnormal dendritic spines. Reduced short-term plasticity.)
2q31.1 (SLC25A12) Mitochondrial Ca2+-binding carrier (Growth retardation. Tremors, myelination and motor defects. Die E18–P15.)
3p25.3 (OXTR) GPCR for oxytocin (Abnormal maternal behavior. Hypoactivity, increased aggression and USV in males. Social memory defects. Fewer GABAergic 
synapses.)
7q31.2 (MET) Receptor tyrosine kinase (Muscle, axon guidance, placenta, and liver defects. Die by E14. Abnormal cortical dendrites/spines and hyperconnectivity of 
local circuits in conditional mutant.)
7q22.1 (RELN) Large secreted ECM protein involved 
in cell-cell interactions 
(Reduced body size and premature death in some mutants. Retinal, olfactory, and fertility defects. Various neuron structural, 
functional, and localization abnormalities. Impaired PPI and LTP and reduced inhibitory tone in heterozygotes.)
7q36.3 (EN2) Homeobox TF critical for hindbrain 
patterning
(Deficits in cerebellar development. Altered DA neuron generation and degeneration. Hyperactivity. Motor, learning, and 
grooming impairments.) 
12q14.2 (AVPR1A) GPCR for arginine vasopression (Impaired spatial memory and reduced PPI. Social deficits in females. Reduced anxiety-like behaviors in males.)
17q21.32 (ITGB3) Mediates platelet cell adhesion and 
cell-surface signaling
(Platelet defects, anemia, internal bleeding, increased bone mass, hypocalcemia, and premature death. 50% die embryonically 
from placental defects. Altered social and repetitive behaviors.)
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This SnapShot presents genes and chromosomal regions implicated in risk for autism spectrum disorder and a summary of reported phenotypes of their mouse model counter-
parts. Due to space limitations, we were unable to show genes for which there is no reported mouse phenotype. These include the following:
TYPE OF SYNDROME/VARIANT CHR (GENE) PROTEIN FUNCTION NEURODEVELOPMENTAL PHENOTYPES
Mendelian Syndrome Xp22.13 (CDKL5) Encodes a cyclin-dependent kinase-like 
5, a Ser-Thr protein kinase member
X-linked infantile spasm syndrome
Rare variant 1q21.1 N/A ASD, ID, SCZ, ADHD, EPI
Rare variant 7q11.23 N/A ASD, ID, language delay
Rare variant 11q13.3-q13.4 
(SHANK2)
Encodes a PSD scaffold protein ASD, ID
Rare variant 16p13.3 (A2BP1) Encodes an RNA-binding protein; altered 
splicing in ASD brain
ID, ASD, EPI, SCZ, ADHD
Rare variant 17q12 N/A ASD, SCZ, EPI
Rare variant 22q13.33 N/A Phelan McDermid syndrome
Rare variant Xp22.11 (PTCHD1) Encodes a transmembrane protein struc-
turally similar to sonic hedgehog
ASD, ID
1ASD occurs as a secondary diagnosis in some individuals with these syndromes
*Positive SNP associations with ASD
Abbreviations:  CHR, chromosome; LTD, long-term depression; LTP, long-term potentiation; PPI, prepulse inhibition; E/I, excitatory/inhibitory; PSD, postsynaptic density; ASD, 
autism spectrum disorders; SCZ, schizophrenia; ADHD, attention deficit hyperactivity disorder; ID, intellectual disability; XLID, X-linked intellectual disability; LIS, lissencephaly; 
EPI, epilepsy; OCD, obsessive compulsive disorder; TS, Tourette syndrome; SLI, speech and language impairment; USV, ultrasonic vocalization; TF, transcription factor; ECM, 
extracellular matrix; GPCR, G-protein-coupled receptor. 
REFERENCES
Banerjee-Basu, S. and Packer, A. (2010). SFARI Gene: an evolving database for the autism research community. Dis. Model Mech. 3, 133-5. (https://sfari.org/resources/sfari-gene)
Ehninger, D., Li, W., Fox, K., Stryker, M. P., and Silva, A. J. (2008). Reversing neurodevelopmental disorders in adults. Neuron 60, 950-60.
Ey, E., Leblond, C. S., and Bourgeron, T. (2011). Behavioral profiles of mouse models for autism spectrum disorders. Autism Res. 4, 5-16.
Horev, G., Ellegood, J., Lerch, J. P., Son, Y. E., Muthuswamy, L., Vogel, H., Krieger, A. M., Buja, A., Henkelman, R. M., Wigler, M., and Mills, A. A. (2011) Dosage-dependent phenotypes 
in models of 16p11.2 lesions found in autism. Proc. Natl. Acad. Sci. U. S. A. 
Penagarikano, O., Abrahams, B. S., Herman, E. I., Winden, K. D., Gdalyahu, A., Dong, H., Sonnenblick, L. I., Gruver, R., Almajano, J., Bragin, A., Golshani, P., Trachtenberg, J. T., Peles, 
E., and Geschwind, D. H. (2011) Absense of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell 147, 235-46.
Scherer, S. W. and Dawson, G. (2011). Risk factors for autism: translating genomic discoveries into diagnostics. Hum. Genet. 130, 123-48.
http://www.informatics.jax.org/
http://omim.org/418.e1 Neuron 72, October 20, 2011 ©2011 Elsevier Inc. DOI 10.1016/j.neuron.2011.10.007
